logo
15:58 Feb 26

Morepen Laboratories Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
44.65
+0.47 (+1.06%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Morepen Laboratories Ltd. Financials

Morepen Laboratories Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
44.65
+0.47 (+1.06%)
15:58 Feb 26
Quality
image/svg+xml

48/100
Medium Financial Strength

Valuation
image/svg+xml

37/100
Mid Valuation

Technical

47/100
Technically Neutral

Strength

7

Weakness

0

Opportunity

0

Threats

0

10.20 %

ROE %

6.63 %

ROA %

1.81

EPS

21.10

BVPS

6.51 %

Net Profit Margin

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM 2025
Net Sales
1546.83 1417.53 1690.43 1811.58 1786.83
Operating Expenses +
1410.16 1338 1531.81 1637.51 1643.43
Raw Material
1059.36 939.26 1060.31 1206.43 1157.06
Increase Decrease in Cost
-10.04 16.48 2.11 -47.12 -17.4
Other Manufacturing Expense
0 0 0 0 44.78
Employee Cost
164.25 154.68 181.47 208.91 230.99
Miscellaneous Expenses
721.05 543.28 641.92 683.79 228
Operating Profit
136.67 79.53 158.62 174.07 143.4
Other Income
10.31 6.13 13.97 18.36 17.47
Depreciation
27.64 27.93 33.47 28.98 47.16
Interest
-7.37 1.98 3.71 8.34 17.21
Profit before tax and exceptio..
126.7 55.76 135.42 155.11 96.5
Exceptional Items
0 0 0 0 25.83
PBT
126.7 55.76 135.42 155.11 70.67
Provision for Taxation
25.02 17.08 38.8 37.09 22.09
Net Profit
101.68 38.68 96.62 118.02 100.26
NET Profit after MI
101.68 38.68 96.16 118.02 99.45
EPS
2.26 0.77 1.88 2.2 1.8
Operating Profit Margin (%)
8.84 5.61 9.38 9.61 8.03
Net Profit Margin (%)
6.57 2.73 5.69 6.51 5.57

Morepen Laboratories Ltd. Shareholding

Promoter

FII

Public

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 35.60 35.60 35.60 35.60 35.60 35.60
FII 1.60 1.60 1.70 1.90 2.20 2.10
Public 1.30 1.50 1.50 1.70 1.70 1.70
Others 61.50 61.30 61.20 60.80 60.50 60.60
Shareholder Shares Holding %
Research 360 logo
Download Our App On: